Triosephosphate Isomerase Deficiency: E105D Mutation in Unrelated Patients and Review of the Literature
Open Access
- 19 January 2023
- journal article
- review article
- Published by S. Karger AG in Molecular Syndromology
- Vol. 14 (3) , 231-238
Abstract
Introduction: Chronic haemolytic anaemia, increased susceptibility to infections, cardiomyopathy, neurodegeneration, and death in early childhood are the clinical findings of triosephosphate isomerase (TPI) deficiency, which is an ultra-rare disorder. The clinical and laboratory findings and the outcomes of 2 patients with TPI deficiency are reported, with a review of cases reported in the literature. Case Presentation: Two unrelated patients with haemolytic anaemia and neurologic findings who were diagnosed as having TPI deficiency are presented. Neonatal onset of initial symptoms was observed in both patients, and the age at diagnosis was around 2 years. The patients had increased susceptibility to infections and respiratory failure, but cardiac symptoms were not remarkable. Screening for inborn errors of metabolism revealed a previously unreported metabolic alteration determined using tandem mass spectrometry in acylcarnitine analysis, causing elevated propionyl carnitine levels in both patients. The patients had p.E105D (c.315G>C) homozygous mutations in the TPI1 gene. Although severely disabled, both patients are alive at the ages of 7 and 9 years. Discussion: For better management, it is important to investigate the genetic aetiology in patients with haemolytic anaemia with or without neurologic symptoms who do not have a definitive diagnosis. The differential diagnosis of elevated propionyl carnitine levels using tandem mass spectrometry screening should also include TPI deficiency.Keywords
This publication has 16 references indexed in Scilit:
- Structural and Genetic Studies Demonstrate Neurologic Dysfunction in Triosephosphate Isomerase Deficiency Is Associated with Impaired Synaptic Vesicle DynamicsPLOS Genetics, 2016
- Hemolytic Anemia and Progressive Neurologic Impairment: Think About Triosephosphate Isomerase DeficiencyFetal and Pediatric Pathology, 2014
- Mild hemolytic anemia, progressive neuromotor retardation and fatal outcome: a disorder of glycolysis, triose- phosphate isomerase deficiency.2013
- Triosephosphate Isomerase Deficiency: A Patient With Val231Met MutationPediatric Neurology, 2011
- Triosephosphate isomerase deficiency: New insights into an enigmatic diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Triosephosphate isomerase deficiency with elevated sweat chloride test: report of a caseThe Turkish Journal of Pediatrics, 2000
- Triose phosphate isomerase deficiency in 3 French families: two novel null alleles, a frameshift mutation (TPI Alfortville) and an alteration in the initiation codon (TPI Paris).2000
- Towards enzyme-replacement treatment in triosephosphate isomerase deficiencyThe Lancet, 1999
- Triosephosphate isomerase deficiency: Repetitive occurrence of point mutation in amino acid 104 in multiple apparently unrelated familiesAmerican Journal of Hematology, 1995
- Hereditary triose phosphate isomerase deficiency: seven new homozygous casesHuman Genetics, 1985